BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 25, 2021
View Archived Issues
KAT7 identified as a driver of cellular senescence
Read More
MediciNova initiates phase II trial of ibudilast in COVID-19 patients at risk of ARDS
Read More
First-in-human study evaluates EMB-02 for advanced solid tumors
Read More
In situ-gelling hydrogel with tunable properties for intranasal drug delivery to the brain
Read More
Hyper-IL-6 gene therapy stimulates axon regeneration and functional recovery after SCI in mice
Read More
Antibody-drug conjugates with new PNU-159682 derivatives show anticancer efficacy in vivo
Read More
Orladeyo approved in Japan for the prophylactic treatment of hereditary angioedema
Read More
Qilu Regor Therapeutics patents MALT1 inhibitors
Read More
Lundbeck discloses new antidepressants
Read More
Galecto Biotech identifies new LGALS1 and/or LGALS3 inhibitors
Read More
BeiGene presents new MAP4K1 inhibitors
Read More
New IL-10 variant proteins presented by Korean investigators
Read More
Funding supports Vaxess' work on mRNA-based single-dose, refrigeration-free vaccine patch
Read More
Elasmogen identifies novel anti-COVID-19 therapeutic candidates
Read More
Molecularly, skin disease shares much with development
Read More
FDA approves Lupkynis oral therapy for lupus nephritis
Read More
Hunterase ICV approved in Japan for MPS II
Read More
BirchBioMed reports phase II data on FS-2 for keloid scars
Read More
Novel GLP-1 and FGF-21 dual agonist D-1 shows potential for diabetes and NASH
Read More
Japanese approval for Yescarta for relapsed or refractory DLBCL
Read More
Antengene receives Chinese clearance for phase II/III study of selinexor for DLBCL
Read More
Phase III studies of faricimab in wet AMD meet primary endpoint
Read More
FDA approves Cabometyx plus Opdivo for advanced RCC
Read More
Neuregulin-1 beta 1 linked to early phase multiple sclerosis pathogenesis
Read More
Zydus reports phase IIb data on desidustat in patients with COVID-19
Read More
COLCORONA trial shows colchicine reduces risk of COVID-19-related complications
Read More
Japanese approval of Calquence for relapsed or refractory CLL
Read More
